RESTENOSIS RISK FACTORS AFTER CORONARY ARTERY STENTING IN OBESE PATIENTS

RESTENOSIS RISK FACTORS AFTER CORONARY ARTERY STENTING IN OBESE PATIENTS

Aim. To assess the role of epicardial obesity (O) and other metabolic factors in the development of coronary artery (CA) restenosis after CA stenting.Material and methods. The study included 68 men with coronary heart disease (CHD), Functional Class II–III effort angina, aged 38–70 years (mean age 5...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Veselovskaya, G. A. Chumakova, V. A. Elykomov, O. V. Gritsenko, A. A. Dashkova, E. V. Trubina, E. V. Kiseleva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	epicardial obesity adipokines coronary artery stenting cardiovascular complications
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/186
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

RISK FACTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN POSTMENOPAUSAL WOMEN WITH OBESITY
by: E. S. Osipova, et al.
Published: (2018-06-01)

EPICARDIAL OBESITY AND A RANGE OF METABOLIC RISK FACTORS RELATION WITH THE PREVALENCE INDEX OF CORONARY ATHEROSCLEROSIS
by: G. A. Chumakova, et al.
Published: (2015-04-01)

Research advances in the etiology of in-stent restenosis of coronary arteries
by: Hangrui Bai, et al.
Published: (2025-07-01)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Clinical condition and cardiovascular risk factors displaying neoatherosclerosis in stented coronary arteries with developing restenosis
by: V. P. Mazaev, et al.
Published: (2016-10-01)

A NON-INVASIVE MARKER OF INSULIN RESISTANCE IN PATIENTS WITH OBESITY
by: N. G. Veselovskaya, et al.
Published: (2013-12-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

SPECIFICS OF MYOCARDIAL INFARCTION IN OBESITY
by: G. A. Chumakova, et al.
Published: (2017-05-01)

Morphological and functional characteristics of retrosternal adipose tissue and their relation to arterial stiffness parameters in patients after coronary artery bypass grafting
by: N. V. Naryzhnaya, et al.
Published: (2020-07-01)

Antioxidant system gene polymorphism and restenosis risk after coronary stenting
by: Yu. A. Shuvalova, et al.
Published: (2008-10-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Role of epicardial adipose tissue in the development of cardiovascular diseases
by: I. A. Mustafina, et al.
Published: (2022-03-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

A Subtraction Coronary Computed Tomography Angiography Technique to Evaluate In-stent Restenosis
by: Yan ZHOU, et al.
Published: (2025-07-01)

ALTERNATIVE METHOD OF VISCERAL OBESITY ASSESSMENT IN THE DIAGNOSTICS OF METABOLIC SYNDROME
by: N. G. Veselovskaya, et al.
Published: (2014-03-01)

Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01)

CLINICAL APPLICATION OF QUANTITATIVE ECHOCARDIOGRAPHIC ASSESSMENT OF EPICARDIAL FAT TISSUE IN OBESITY
by: T. Yu. Kuznetsova, et al.
Published: (2017-05-01)

Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01)

Pre‐Percutaneous Coronary Intervention C‐Reactive Protein Levels and In‐Stent Restenosis: A Systematic Review and Meta‐Analysis
by: Himanshu Rai, et al.
Published: (2025-05-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series
by: Pivina L, et al.
Published: (2025-01-01)

Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease
by: T. A. Batyraliev, et al.
Published: (2011-08-01)

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes
by: Yan Han, et al.
Published: (2024-11-01)

Predicting the risk of left ventricular diastolic dysfunction in obesity
by: G. A. Chumakova, et al.
Published: (2022-05-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

The relationship of epicardial obesity and levels of cardiac fibrosis markers
by: O. V. Gritsenko, et al.
Published: (2019-05-01)

CLINICAL SPECIFICS OF PATIENTS STATE AFTER REVASCULARIZED MYOCARDIAL INFARCTION, DEPENDING ON THE BASELINE OBESITY STATUS
by: G. A. Chumakova, et al.
Published: (2018-06-01)

Intravascular ultrasound assessment of stent edge restenosis mechanisms and treatment outcomes following percutaneous coronary intervention
by: Xi Wu, et al.
Published: (2025-05-01)

Possibilities for managing the left ventricular diastolic dysfunction risk in obese patients
by: O. V. Gritsenko, et al.
Published: (2023-05-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Comparative analysis of third-generation dual-energy CT and IVUS for in-stent restenosis detection
by: Mohey E. A. Eldeeb, et al.
Published: (2025-08-01)

Predictors of angina pain relapse after coronary stenting for acute coronary syndrome in Buryats
by: E. M. Zelenskaya, et al.
Published: (2023-11-01)

Advanced chronic total occlusion–percutaneous coronary intervention techniques in managing complex in-stent restenosis
by: Gautam Swaroop
Published: (2025-05-01)

Current Techniques of Intravascular Imaging and Implantation of Bioresorbable Coronary Vascular Scaffolds (Stents)
by: I. E. Nikolaeva, et al.
Published: (2019-07-01)

The role of epicardial adipose tissue in the development of atrial fibrillation: a literature review
by: I. V. Tarasova, et al.
Published: (2024-08-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

RESTENOSIS AND IN-STENT STENOSIS: PATHOGENETIC MECHANISMS AND PROGNOSTIC MARKERS
by: G. A. Berezovskaya, et al.
Published: (2012-12-01)